WIRES NANOMED NANOBI 润色咨询

Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

出版年份:2008 年文章数:532 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:3.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1104121, encodeId=fe2111041215f, content=引言和讨论的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104122, encodeId=673a1104122ad, content=怎么撰写引言?区别于讨论?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544130, encodeId=5a3c544130d2, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523656, encodeId=df7652365685, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:因子很高,好像比去年低了点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67421736960, createdName=laorui, createdTime=Wed Jun 15 09:07:00 CST 2016, time=2016-06-15, status=1, ipAttribution=)]
    2021-12-29 小动量

    引言和讨论的区别?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1104121, encodeId=fe2111041215f, content=引言和讨论的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104122, encodeId=673a1104122ad, content=怎么撰写引言?区别于讨论?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544130, encodeId=5a3c544130d2, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523656, encodeId=df7652365685, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:因子很高,好像比去年低了点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67421736960, createdName=laorui, createdTime=Wed Jun 15 09:07:00 CST 2016, time=2016-06-15, status=1, ipAttribution=)]
    2021-12-29 MS54455111222

    怎么撰写引言?区别于讨论?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1104121, encodeId=fe2111041215f, content=引言和讨论的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104122, encodeId=673a1104122ad, content=怎么撰写引言?区别于讨论?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544130, encodeId=5a3c544130d2, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523656, encodeId=df7652365685, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:因子很高,好像比去年低了点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67421736960, createdName=laorui, createdTime=Wed Jun 15 09:07:00 CST 2016, time=2016-06-15, status=1, ipAttribution=)]
    2017-07-16 wang_di98

    徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1104121, encodeId=fe2111041215f, content=引言和讨论的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104122, encodeId=673a1104122ad, content=怎么撰写引言?区别于讨论?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544130, encodeId=5a3c544130d2, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523656, encodeId=df7652365685, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:因子很高,好像比去年低了点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67421736960, createdName=laorui, createdTime=Wed Jun 15 09:07:00 CST 2016, time=2016-06-15, status=1, ipAttribution=)]
    2016-06-15 laorui

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:因子很高,好像比去年低了点。

    0

共6条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分